טוען...

Japanese Surveillance of Neuroendovascular Therapy in JR-NET - Part II. Japanese Registry of NeuroEndovascular Treatment 3. Main Report

This study, following Japanese Registry of NeuroEndovascular Treatment 1 and 2 (JR-NET 1 & 2), shows an annual trend of cases including adverse events and clinical outcomes at 30 days after NET. JR-NET3 was registered by 749 cumulative total number of physicians, certified by the Japanese Societ...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Neurol Med Chir (Tokyo)
Main Authors: SAKAI, Nobuyuki, UCHIDA, Kazutaka, IIHARA, Koji, SATOW, Tetsu, EZURA, Masayuki, HYODO, Akio, MIYACHI, Shigeru, MIYAMOTO, Susumu, NAGAI, Yoji, NISHIMURA, Kunihiro, TOYODA, Kazunori, YOSHIMURA, Shinichi, IMAMURA, Hirotoshi, SAKAI, Chiaki, MATSUMARU, Yuji
פורמט: Artigo
שפה:Inglês
יצא לאור: The Japan Neurosurgical Society 2019
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6434423/
https://ncbi.nlm.nih.gov/pubmed/30842388
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2176/nmc.oa.2018-0267
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!